Acceleron, Celgene Offer Updated Results from Ongoing Phase 2 Study of Luspatercept
June 10, 2016 at 07:02 AM EDT
Acceleron Pharma Inc. (NASDAQ: XLRN) and Celgene Corporation (NASDAQ: CELG) today announced that preliminary results will be presented ...